Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
KIR2DL3/CD158b2 Antibody (190IIC311), Janelia Fluor™ 646, Novus Biologicals™
Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP104316JF646
Description
KIR2DL3/CD158b2 Monoclonal specifically detects KIR2DL3/CD158b2 in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunocytochemistry/Immunofluorescence.Specifications
KIR2DL3/CD158b2 | |
Monoclonal | |
Janelia Fluor 646 | |
50mM Sodium Borate with 0.05% Sodium Azide | |
KIR2DL3 | |
Recombinant human KIR2DL3 | |
0.1 mL | |
Primary | |
Anti-Hu KIR2DL3 mAb, clone 190IIC311, is derived from hybridization of mouse P3-x63-Ag8.653 myeloma cells with spleen cells from BALB/c mice immunized with recombinant KIR2DL3. | |
Store at 4°C in the dark. | |
IgG2a |
Western Blot, Flow Cytometry, ELISA, Immunocytochemistry, Immunofluorescence | |
190IIC311 | |
Western Blot, Flow Cytometry, ELISA, Immunocytochemistry/Immunofluorescence | |
CD158 antigen-like family member B2, CD158b2 antigen, CD158B2CD158b, cl-6, killer cell immunoglobulin-like receptor 2DL3, killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3, Killer inhibitory receptor cl 2-3, KIR-023GB, KIRCL23, KIR-K7b, KIR-K7c, MGC129943, MHC class I NK cell receptor, natural killer associated transcript 2, natural killer cell inhibitory receptor KIR2DL3, Natural killer-associated transcript 2, NKAT, nkat2, NKAT-2, NKAT2a, NKAT2B, NKAT2GL183, NK-receptor, p58, p58 natural killer cell receptor clone CL-6, p58 NK receptor CL-6, p58.2 MHC class-I specific NK receptor, p58.2 MHC class-I-specific NK receptor | |
Mouse | |
Protein G purified | |
Apoptosis | |
3804 | |
Human | |
Purified |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction